Koni, E.; Wanha, W.; Ratajczak, J.; Zhang, Z.; Podhajski, P.; Musci, R.L.; Sangiorgi, G.M.; Kaźmierski, M.; Buffon, A.; Kubica, J.;
et al. Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. J. Clin. Med. 2021, 10, 1278.
https://doi.org/10.3390/jcm10061278
AMA Style
Koni E, Wanha W, Ratajczak J, Zhang Z, Podhajski P, Musci RL, Sangiorgi GM, Kaźmierski M, Buffon A, Kubica J,
et al. Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Journal of Clinical Medicine. 2021; 10(6):1278.
https://doi.org/10.3390/jcm10061278
Chicago/Turabian Style
Koni, Endrin, Wojciech Wanha, Jakub Ratajczak, Zhongheng Zhang, Przemysław Podhajski, Rita L. Musci, Giuseppe M. Sangiorgi, Maciej Kaźmierski, Antonio Buffon, Jacek Kubica,
and et al. 2021. "Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention" Journal of Clinical Medicine 10, no. 6: 1278.
https://doi.org/10.3390/jcm10061278
APA Style
Koni, E., Wanha, W., Ratajczak, J., Zhang, Z., Podhajski, P., Musci, R. L., Sangiorgi, G. M., Kaźmierski, M., Buffon, A., Kubica, J., Wojakowski, W., & Navarese, E. P.
(2021). Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Journal of Clinical Medicine, 10(6), 1278.
https://doi.org/10.3390/jcm10061278